Modified-release dosage forms present new opportunities for drug developers and can help overcome challenges, such as short biological half-life or poor bioavailability due to degradation in the stomach.
Torkel Gren
Advertisement
Torkel Gren is senior director, Technology Officer & Strategic Investments at Recipharm.
Articles by Torkel Gren
Advertisement
Latest Updated Articles
- Modified Release: A Pathway to More Patient-Friendly Medication
Published: June 30th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
2
Takeda’s Sriman Banerjee Discusses Smart Packaging at CPHI Frankfurt 2025
3
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
4
Standardizing Operations to Meet Global Sustainability and Resilience Goals
5
